Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)
Rabadi, A., Alsmadi, M., Almashagbeh, R., Banihamad, Y., AL-Qudah, T. (2021). Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR). EKB Journal Management System, 83(1), 1162-1164. doi: 10.21608/ejhm.2021.161771
Aeham Rabadi; Mohammad Alsmadi; Rayya Almashagbeh; Yazan Banihamad; Tareq AL-Qudah. "Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)". EKB Journal Management System, 83, 1, 2021, 1162-1164. doi: 10.21608/ejhm.2021.161771
Rabadi, A., Alsmadi, M., Almashagbeh, R., Banihamad, Y., AL-Qudah, T. (2021). 'Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)', EKB Journal Management System, 83(1), pp. 1162-1164. doi: 10.21608/ejhm.2021.161771
Rabadi, A., Alsmadi, M., Almashagbeh, R., Banihamad, Y., AL-Qudah, T. Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR). EKB Journal Management System, 2021; 83(1): 1162-1164. doi: 10.21608/ejhm.2021.161771

Acute Myocradial Infarction, Primary Percutanious Coronary Intervention (PCI) in an Anticoagulated Patient for Mitalic Mitral Valve Replacement (MVR)

The Egyptian Journal of Hospital Medicine
Article 55, Volume 83, Issue 1, April 2021, Page 1162-1164  XML PDF (410.74 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2021.161771
View on SCiNiTO View on SCiNiTO
Authors
Aeham Rabadi email 1; Mohammad Alsmadi2; Rayya Almashagbeh1; Yazan Banihamad1; Tareq AL-Qudah1
1Cardiology Department, Queen Alia Heart Institute (QAHI), Royal Medical Services (RMS), Jordan
2Gastroentrology Department, King Husain Medical City, Royal Medical Services (RMS), Jordan
Abstract
Valvular heart diseases and atrial fibrillation are ones of the most common indications for oral anticoagulation, in the same time they are known risk factors for coronary artery disease and presentation of acute coronary syndrome, which may need urgent management by primary percutaneous intervention.
Acute myocardial infarction is commonly seen in these patients with suboptimal anticoagulation, but it is almost seldomly seen when anticoagulation is in therapeutic range.
This is the first case reporting an acute myocardial infarction (MI) in a patient post mitral valve replacement (MVR) and high International Normalization Ratio (INR), which has not been reported before.
Keywords
Acute myocardial infarction; Major bleeding; Percutaneouscoronary intervention; Warfarin
Statistics
Article View: 186
PDF Download: 330